戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 the basis for the immunologic attack seen in Graves ophthalmopathy.
2  leading to the clinical findings typical of Graves ophthalmopathy.
3 ent of lower lid retraction in patients with Graves ophthalmopathy.
4  to the intense inflammation associated with Graves' ophthalmopathy.
5 y a role in the etiology and pathobiology of Graves' ophthalmopathy and/or other ocular myopathies.
6                                              Graves ophthalmopathy (GO) is an autoimmune disease that
7                                              Graves' ophthalmopathy (GO) affects 50% to 60% of patien
8              Appearances of and increases in Graves' ophthalmopathy (GO) have been reported after tre
9 isease (GD) is a common thyroid disease, and Graves ophthalmopathy(GO) is the most common extra-thyro
10                   The surgical management of Graves ophthalmopathy includes treatment of globe malpos
11  for those undergoing the orbital changes of Graves' ophthalmopathy is often challenging, even as our
12 fic situations, for example, Duane syndrome, Graves' ophthalmopathy, may be particularly problematic.
13                                          The Graves' Ophthalmopathy Quality of Life (GO-QOL) scale wa
14  Clinical Activity Score, and results on the Graves' ophthalmopathy-specific quality-of-life question
15 ve involvement of the extraocular muscles in Graves' ophthalmopathy, the absence of N-CAM expression
16 lasts or fat accumulation, such as occurs in Graves' ophthalmopathy, tissue fibrosis, abnormal wound
17  was a retrospective review of patients with Graves ophthalmopathy undergoing lower eyelid retraction

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。